Bath & Body Works (NYSE:BBWI) Earns Outperform Rating from Telsey Advisory Group

Key Points

• Bath & Body Works has received an "outperform" rating from Telsey Advisory Group with a price target of $38.00, indicating a potential upside of 27.75% from its current price.
• Analysts from various firms have adjusted their price targets for Bath & Body Works, with Goldman Sachs lowering theirs to $43.00, while Wells Fargo has raised theirs to $44.00.
• The company reported earnings of $0.37 EPS for the last quarter, beating expectations, and its fiscal year 2025 guidance is projected at 3.350-3.600 EPS.

Bath & Body Works (NYSE:BBWI - Get Free Report)'s stock had its "outperform" rating reaffirmed by stock analysts at Telsey Advisory Group in a research report issued on Thursday,Benzinga reports. They currently have a $38.00 price target on the stock. Telsey Advisory Group's price objective points to a potential upside of 27.75% from the stock's current price.

Other equities research analysts have also recently issued research reports about the stock. The Goldman Sachs Group reduced their target price on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research note on Friday, May 30th. Morgan Stanley reduced their target price on shares of Bath & Body Works from $49.00 to $43.00 and set an "overweight" rating for the company in a research note on Tuesday, May 6th. Barclays reduced their target price on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating for the company in a research note on Friday, May 30th. Wells Fargo & Company increased their target price on shares of Bath & Body Works from $40.00 to $44.00 and gave the company an "overweight" rating in a research note on Wednesday, May 14th. Finally, JPMorgan Chase & Co. increased their target price on shares of Bath & Body Works from $40.00 to $46.00 and gave the company an "overweight" rating in a research note on Monday, July 28th. Fourteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $42.53.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI opened at $29.75 on Thursday. The company has a market cap of $6.29 billion, a P/E ratio of 7.81, a P/E/G ratio of 1.05 and a beta of 1.54. The stock's 50-day moving average is $30.58 and its 200-day moving average is $30.90. Bath & Body Works has a 52-week low of $24.94 and a 52-week high of $41.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.01. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.During the same period in the prior year, the company earned $0.37 EPS. The company's revenue for the quarter was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, equities analysts predict that Bath & Body Works will post 3.3 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Stonehage Fleming Financial Services Holdings Ltd bought a new stake in Bath & Body Works during the 2nd quarter worth approximately $33,000. SVB Wealth LLC bought a new stake in Bath & Body Works during the 1st quarter worth approximately $35,000. Geneos Wealth Management Inc. grew its position in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock worth $35,000 after acquiring an additional 801 shares during the last quarter. Parallel Advisors LLC grew its position in Bath & Body Works by 63.3% during the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company's stock worth $37,000 after acquiring an additional 481 shares during the last quarter. Finally, Golden State Wealth Management LLC grew its position in Bath & Body Works by 94.7% during the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after acquiring an additional 642 shares during the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.